• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • US Melanoma Companies

    ID: MRFR/Pharma/2164-HCR
    50 Pages
    Kinjoll Dey
    September 2025

    Pioneering advancements in dermatological care, US Melanoma companies specialize in research, treatment, and patient support. Focused on combating melanoma, these organizations contribute to the understanding and management of skin cancer, offering innovative therapies that aim to improve outcomes and enhance the lives of those affected.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the US Melanoma Market

    US Melanoma Key Companies

     

    Latest US Melanoma Companies Update


    Merck Sharp & Dohme (MSD) Receives FDA Approval for KEYTRUDA® (pembrolizumab) in Combination with YERVOY® (ipilimumab) for First-Line Treatment of Advanced/Unresectable Stage III Melanoma: This January 2024 approval expands treatment options for patients with advanced melanoma, offering a potentially more effective combination therapy.


    Bristol-Myers Squibb (BMS) Announces Positive Phase 3 Results for Opdivo® (nivolumab) in Combination with RELIBRANT® (nivolumab + ipilimumab) for Adjuvant Treatment of Stage


    III Melanoma: December 2023 development suggests the potential of this combination therapy to improve long-term survival outcomes in high-risk Stage III melanoma patients.


    IO Biotech Partners with Regeneron to Develop Novel Immunotherapy for Melanoma: January 2024 collaboration combines expertise to accelerate the development of IOB-C100, a potential new class of immunotherapy targeting the LAG-3 immune checkpoint.


    List of US Melanoma Key Companies in the Market



    • Amgen Inc.

    • Bristol-Myers Squibb

    • Eisai Co. Ltd.

    • Hoffmann-La Roche Ltd.

    • Genentech Inc. Janssen Biotech Inc.

    • and Novartis International AG. Pfizer

    • Vical

    • Ziopharm